Liquidia Continues To Expand Their Growth Vs. MannKind's Growth In Share Prices [Seeking Alpha]
Liquidia Corporation (LQDA)
Last liquidia corporation earnings: 3/11 07:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
Liquidia's PAH drug, Yutrepia, is expected to launch in the first or second quarter of 2024, potentially leading to profitability. Liquidia has gained a major partnership for a sustained-release inhaled Treprostinil product, which could compete with United Therapeutics' revenue products. On June 29, 2022, I had an SA article titled Liquidia ( LQDA ) vs. MannKind ( MNKD Treprostinil Is the Big ‘IF At the end of the article, I indicated to the readers that my choice in the contest as to who would dominate the market with their respective PAH drug, the winner would be Liquidia. Eighteen months later, Liquidia's stock has increased by more than 200%. This dramatic increase in their share price has changed my short-term thesis for the stock. However, my long-term thesis remains in place. But any prudent investor should take advantage of their ownership in a stock that has more than doubled if they have identified another stock that might offer the same growth potential in the near t
Show less
Read more
Impact Snapshot
Event Time:
LQDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LQDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LQDA alerts
High impacting Liquidia Corporation news events
Weekly update
A roundup of the hottest topics
LQDA
News
- Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline [Yahoo! Finance]Yahoo! Finance
- When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable? [Yahoo! Finance]Yahoo! Finance
- Liquidia Co. (NASDAQ: LQDA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.MarketBeat
- Liquidia Corporation (NASDAQ:LQDA) has caught the attention of institutional investors who hold a sizeable 38% stake [Yahoo! Finance]Yahoo! Finance
- Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
LQDA
Earnings
- 11/7/23 - Miss
LQDA
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- 4/29/24 - Form DEF
- LQDA's page on the SEC website